06:04 AM EST, 02/14/2025 (MT Newswires) -- Theratechnologies Inc. ( THTX ) , a specialty biopharmaceutical company, late on Thursday said it has resumed distribution of EGRIFTA SV(r) tesamorelin for injection.

The move follows the U.S. Food and Drug Administration green light allowing the company to release two recently manufactured batches of EGRIFTA SV(r).

The product is ready for immediate shipment to network pharmacies, the company said.

"We remain committed to providing EGRIFTA SV(r) to people with HIV and we truly appreciate the FDA's collaboration to get the treatment back to the patients who rely on it," said Christian Marsolais, senior vice president and chief medical officer at Theratechnologies ( THTX ).

EGRIFTA SV(r) is distributed only in the United States.